Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.715
-0.145 (-7.80%)
May 6, 2025, 3:16 PM EDT - Market open
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$1,625
Profits / Employee
-$800,404
Market Cap
62.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
INO News
- 6 days ago - INOVIO to Present at Upcoming Scientific and Investor Conferences - PRNewsWire
- 7 days ago - INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - PRNewsWire
- 27 days ago - INOVIO to Present at Upcoming Scientific Conferences - PRNewsWire
- 6 weeks ago - Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - PRNewsWire
- 7 weeks ago - INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 - PRNewsWire
- 7 weeks ago - INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025 - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript) - Seeking Alpha